Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2006

de Reyniès A, Geromin D, Cayuela J-, Petel F, Dessen P, Sigaux F, et al. Comparison of the latest commercial short and long oligonucleotide microarray technologies. BMC Genomics. 2006;7:51.

Oh WK, Hayes J, Evan C, Manola J, George DJ, Waldron H, et al. Development of an integrated prostate cancer research information system. Clin Genitourin Cancer. 2006;5(1):61-6.

Rohan S, Tu JJ, Kao J, Mukherjee P, Campagne F, Zhou XK, et al. Gene expression profiling separates chromophobe renal cell carcinoma from oncocytoma and identifies vesicular transport and cell junction proteins as differentially expressed genes. Clin Cancer Res. 2006;12(23):6937-45.

Breza TS, Zheng P, Porcu P, Magro CM. Cutaneous marginal zone B-cell lymphoma in the setting of fluoxetine therapy: a hypothesis regarding pathogenesis based on in vitro suppression of T-cell-proliferative response. J Cutan Pathol. 2006;33(7):522-8.

Seidman JD, Horkayne-Szakaly I, Cosin JA, Ryu HS, Haiba M, Boice CR, et al. Testing of two binary grading systems for FIGO stage III serous carcinoma of the ovary and peritoneum. Gynecol Oncol. 2006;103(2):703-8.

Kellner D, Chen J, Richardson I, Seshan SV, Chaar ME, Vaughan ED, et al. Angiotensin receptor blockade decreases fibrosis and fibroblast expression in a rat model of unilateral ureteral obstruction. J Urol. 2006;176(2):806-12.

Tam W, Gomez M, Chadburn A, Lee JW, Chan WC, Knowles DM. Mutational analysis of PRDM1 indicates a tumor-suppressor role in diffuse large B-cell lymphomas. Blood. 2006;107(10):4090-100.

Qiao X, He B, Chiu A, Knowles DM, Chadburn A, Cerutti A. Human immunodeficiency virus 1 Nef suppresses CD40-dependent immunoglobulin class switching in bystander B cells. Nat Immunol. 2006;7(3):302-10.

A Crowson N, Magro CM, Mihm MC. Malignant adnexal neoplasms. Mod Pathol. 2006;19 Suppl 2:S93-S126.

Ogino S, Odze RD, Kawasaki T, Brahmandam M, Kirkner GJ, Laird PW, et al. Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma. Am J Surg Pathol. 2006;30(9):1175-83.